Search Results

UNC2881 10 mg  | 99.72%

TargetMol

UNC2881 is a specific Mer tyrosine kinase inhibitor (IC50: 4.3 nM). It is about 83- and 58-fold higher selectivity than Axl and Tyro3, respectively.

More Information Supplier Page

Spebrutinib 100 mg  | 97.14%

TargetMol

Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.

More Information Supplier Page

Norgestrel 50 mg  | 99.79%

TargetMol

Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes.

More Information Supplier Page

Norgestrel 100 mg  | 99.79%

TargetMol

Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes.

More Information Supplier Page

Ivacaftor 5 mg  | 98.00%

TargetMol

Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.

More Information Supplier Page

Ivacaftor 50 mg  | 98.00%

TargetMol

Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.

More Information Supplier Page

Ivacaftor 10 mg  | 98.00%

TargetMol

Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.

More Information Supplier Page

Cabozantinib 5 mg  | 99.59%

TargetMol

Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50s: 0.035, 1.3, 4.6, 7 and 11.3 nM).

More Information Supplier Page

Spebrutinib 10 mg  | 97.14%

TargetMol

Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.

More Information Supplier Page

Spebrutinib 50 mg  | 97.14%

TargetMol

Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.

More Information Supplier Page